Pneumonia: Difference between revisions
Ochuko Ajari (talk | contribs) No edit summary |
Ochuko Ajari (talk | contribs) No edit summary |
||
| Line 10: | Line 10: | ||
'''Editor(s)-in-Chief:''' [[C. Michael Gibson, M.S., M.D.]] [mailto:charlesmichaelgibson@gmail.com] Phone:617-632-7753; {{AE}} [[Priyamvada Singh|Priyamvada Singh, M.D.]] [mailto:psingh13579@gmail.com]; [[Philip Marcus, M.D., M.P.H.]][mailto:pmarcus192@aol.com] | '''Editor(s)-in-Chief:''' [[C. Michael Gibson, M.S., M.D.]] [mailto:charlesmichaelgibson@gmail.com] Phone:617-632-7753; {{AE}} [[Priyamvada Singh|Priyamvada Singh, M.D.]] [mailto:psingh13579@gmail.com]; [[Philip Marcus, M.D., M.P.H.]][mailto:pmarcus192@aol.com] | ||
==[[Pneumonia overview|Overview]]== | ==[[Pneumonia overview|Overview]]== | ||
Revision as of 21:09, 14 February 2013
| Pneumonia | |
 |
|---|
|
Pneumonia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pneumonia On the Web |
|
American Roentgen Ray Society Images of Pneumonia |
For patient information click here
Editor(s)-in-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753; Associate Editor(s)-in-Chief: Priyamvada Singh, M.D. [2]; Philip Marcus, M.D., M.P.H.[3]
Overview
Historical Perspective
Classification
Community-Acquired Pneumonia | Hospital-Acquired Pneumonia | Eosinophilic Pneumonia | Desquamative Interstitial Pneumonia | Aspiration Pneumonia | Atypical Pneumonia | Interstitial Pneumonia | Pneumocystis Pneumonia | Mycoplasma Pneumonia
Pathophysiology
Causes
Specific Causes: Bacterial | Fungal | Parasitic | Viral
Differentiating Pneumonia from other Diseases
SARS | Bronchiolitis Obliterans Organizing Pneumonia
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Prognosis Predictor Scores: CURB-65 | Pneumonia Severity Index | Criteria for Severe Community-Acquired Pneumonia
Diagnosis
Diagnostic Criteria | History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | CT | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies